FORMATO, Marilena
 Distribuzione geografica
Continente #
NA - Nord America 3.837
EU - Europa 2.271
AS - Asia 1.126
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 18
SA - Sud America 8
AF - Africa 4
Totale 7.283
Nazione #
US - Stati Uniti d'America 3.812
UA - Ucraina 1.093
CN - Cina 1.066
DE - Germania 365
IT - Italia 239
FI - Finlandia 178
SE - Svezia 169
FR - Francia 78
GB - Regno Unito 76
TR - Turchia 32
BE - Belgio 29
CA - Canada 23
AU - Australia 17
EU - Europa 17
BR - Brasile 8
DK - Danimarca 7
GR - Grecia 5
HR - Croazia 5
IN - India 5
JP - Giappone 5
SG - Singapore 4
IR - Iran 3
LU - Lussemburgo 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
IE - Irlanda 2
IL - Israele 2
MA - Marocco 2
NL - Olanda 2
NO - Norvegia 2
PL - Polonia 2
RU - Federazione Russa 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
EG - Egitto 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
SI - Slovenia 1
VN - Vietnam 1
Totale 7.283
Città #
Chandler 1.028
Jacksonville 684
Princeton 356
Nanjing 294
Dearborn 172
New York 166
Wilmington 147
Nanchang 134
Sassari 122
Ann Arbor 102
Boardman 94
Beijing 87
Shenyang 84
Hebei 71
Changsha 67
Tianjin 59
Jiaxing 46
Woodbridge 45
Andover 39
Jinan 38
Ashburn 36
Zhengzhou 35
Ningbo 34
Kunming 31
Mountain View 31
Brussels 29
Hangzhou 26
Izmir 26
Norwalk 24
San Francisco 22
Toronto 21
Taizhou 15
Guangzhou 14
Villiers-sur-marne 12
Helsinki 11
Changchun 10
Lanzhou 9
Hanover 8
Los Angeles 8
Melbourne 7
Auburn Hills 6
Ficarazzi 6
Oristano 6
Augusta 5
Cagliari 5
London 5
San Mateo 5
Zagreb 5
Canberra 4
Leawood 4
Pátrai 4
Singapore 4
Sydney 4
Tokyo 4
Verona 4
Ardabil 3
Edinburgh 3
Falls Church 3
Bangkok 2
Cedar Knolls 2
Dublin 2
Fairfield 2
Frankfurt am Main 2
Haikou 2
Hefei 2
Luxembourg 2
Monmouth Junction 2
Mumbai 2
Paris 2
Potenza 2
Qingdao 2
Rome 2
San Jose 2
Seattle 2
Serramanna 2
São Paulo 2
Tappahannock 2
Torino 2
Turin 2
Warsaw 2
Acquaviva Delle Fonti 1
Adelaide 1
Agadir 1
Almere Stad 1
Americo Brasiliense 1
Amsterdam 1
Atlanta 1
Baku 1
Belgrade 1
Berlin 1
Brierley Hill 1
Budapest 1
Buffalo 1
Cairo 1
Charlotte 1
Chernihiv 1
Chicago 1
Chieti 1
Chisinau 1
Città Di Castello 1
Totale 4.388
Nome #
Assessment of protein-incorporated arginine methylation in biological specimens by CZE UV-detection 86
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 80
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 73
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 72
A poly-L-lactic acid/ collagen/glycosaminoglycan matrix for tissue engineering applications 70
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 68
A study of the switch of fetal hemoglobin in newborn erythrocytes fractionated by density gradient 68
Short-end injection capillary electrophoresis for quantification of plasma chondroitin sulfate isomer disaccharides 67
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers 66
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 64
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 63
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 63
Polymorphism of foetal haemoglobin in the sardinian Beta+-Thalassaemia. 62
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 62
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 61
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 61
Distribution of low - density lipoprotein-bound low molecular weight thiols: a new analytical approach 60
Polymorphism of foetal haemoglobin in the Sardinian B+-thalassemia 59
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 59
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 57
Hemoglobin Hamilton [β11(A8)Val→Ile] in Sardinia 57
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 55
Diagnosi neonatale delle emoglobinopatie mediante isoelettrofocusing delle Emoglobine 54
A reversed phase HPLC method for the simultaneous determination of all monosaccharides contained in galactosaminoglycan isomers from human aorta proteoglycans 53
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 53
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 52
Dna polymorphisms in north sardinian newborns and their linkage with abnormal globin gene arrangiements and with beta°-thalassemia 51
DNA polymorphisms in north-Sardinian newborns and their linkage with abnormal gamma globin gene arrangements and with B°-thalassemia 51
Lipoprotein(a) and the arterial wall 51
Morfogenesi cronica dei poriferi: la strutturazione della matrice extracellulare è modulata dai glicosaminoglicani? 51
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 51
Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients. IF 2000: 2.071 JCR: Q1 50
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 50
Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus 50
Identification and characterization of biomarkers in atherosclerosis and diabetes. 49
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 49
Oxidative Modifications in Advanced Atherosclerotic Plaques: A Focus on In Situ Protein Sulfhydryl Group Oxidation 49
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 49
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 49
Sequence variability of apolipoprotein E gene in Corsico-Sardinian ovines 48
Albumin-bound low molecular weight thiols analysis in plasma and carotid plaques by CE 48
Urinary excretion of GAGs during hypocholesterolemic therapy 48
Content and distribution of glycosaminoglycans/proteoglycans in human thoracic aortic aneurysm 48
Structural determinants in the C-terminal domain of apolipoprotein E mediating binding to the protein core of human aortic biglycan. IF 2000: 7.368 JCR: Q1 47
Differential proteomic analysis of human atherosclerotic plaque extracts 46
Structural analysis of glycosaminoglycans and proteoglycans from fresh porcine aortic valves 46
Structural and functional modifications of human aorta proteoglycans in atherosclerosis 45
Role of the small proteoglycan bikunin in human reproduction 45
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 45
Buoyant density of Lp(a) subclasses in hypercholesterolemia 45
Evaluation of low molecular mass thiols content in carotid atherosclerotic plaques 44
Cryopreservation of porcine aortic valve: open status of the aortic leaflets results in increased matrix glycosaminoglycan structural maintenance 44
Investigation on the interactions between LDL and proteoglycans from human aortas 44
Apolipoprotein profiles in atherosclerotic disease 44
Apolipoprotein Profiles in Atherosclerotic Disease 44
Apolipoprotein Profiles in Atherosclerotic Disease 44
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 44
Applications of two-dimensional electrophoresis technology to the study of atherosclerosis 44
Protein oxidation in unstable plaque extracts from human carotid segments 43
GAG and protein composition of GAG-protein complexes from normal human plasma 43
Cellular adhesion of rat hepatocytes during the last phase of the phenotype differentiation 43
Estrogen receptors in the liver of intact and gonadectomized rats: determination by hydroxylapatite assay 43
Adhesion properties and proteoglycans produced by subsequent subcultures of rat fibroblasts with different contact inhibition 43
Determination of galactosaminoglycan disaccharides by high performance capillary electrophoresis: applications to analysis of human aorta proteoglycans 42
A proteomic approach to identify circulating or tissue biomarkers of atherosclerosis 42
Atherosclerotic modifications of human proteoglycans 42
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 42
Characterization of a protein-glycosaminoglycan complex in urine from healthy subjects 42
The gamma globin chain heterogeneity of the Sardinian newborn baby. Hemoglobin, 10:519-528, 1986. 42
LDL interactions with different aorta proteoglycans 42
The role of GAGs in cell to cell adhesion of rat fibroblasts: a preliminary investigation 42
GAG content and distribution in porcine aortic valve tissue and in acellular pericardium scaffolds from three mammal species 41
Proteomic analysis of differential protein expression and post-translational modifications in human atherosclerotic plaques 41
Characterization of glycosaminoglycans in human plasma from patients receiving haemodyalisis and their interaction with human LDL 41
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 41
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 41
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 41
IDENTIFICATION, QUANTIFICATION AND STRUCTURAL CHARACTERIZATION OF GLYCOSAMINOGLYCANS FROM PORCINE AORTIC VALVE TISSUE 41
Evidence for a pro-oxidant environment in atherosclerotic plaques from human carotid segments 40
CRYOPRESERVATION OF AORTIC VALVE:OPEN STATUS OF THE AORTIC LEAFLETS RESULTS IN INCREASED MATRIX GLYCOSAMINOGLYCAN MAINTENANCE 40
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 40
Serum Lp(a) levels in chronic haemodialysis patients 40
Modifications of low density lipoprotein induced by the interaction with heparin, chondroitin 6 sulphate and plasma high charge GAG-protein complexes 40
Valorizzazione e sfruttamento sostenibile dei poriferi: la spongicoltura nella fascia costiera 40
Human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 40
Preliminary investigations on LDL interactions with proteoglycans extracted from human aortic wall with different atherosclerotic lesions 40
Cryopreservation of porcine aortic valve on open status increased matrix glycosaminoglycan structural maintenance 40
Generalized absence-like seizures induced by ketamine in the rat 40
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 40
Ldl interaction with proteoglycans isolated from human aortas with different atherosclerotic involvement 40
Urinary glycosaminoglycans in patients with systemic lupus erythematosus 39
Glycosaminoglycan biodiversity in W-Mediterranean marine sponges. 39
Glycosaminoglycan content and distribution in human normal and varicose veins 39
Post-translational modifications of proteoglycans during the development of atherosclerotic lesion 39
Factors affecting S-homocysteinylation of LDL apoprotein B 39
Apolipoprotein profiles in atherosclerotic disease 39
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 39
Morfogenesi cronica dei poriferi: la struttura della matrice extracellulare è modulata dai glicosaminoglicani? 39
Modifications of adhesion properties and proteoglycan structure in rat embryo fibroblast cultures with increasing passages 39
Experimental spongeculture in Sardinian shallow waters: regenerative processes and sponge survival 38
Totale 4.865
Categoria #
all - tutte 29.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.239


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019273 0 0 0 0 0 0 0 0 0 7 3 263
2019/20201.787 525 4 167 15 180 152 283 19 190 48 202 2
2020/20211.249 176 7 206 7 174 38 176 4 200 197 43 21
2021/2022837 110 5 3 16 10 3 54 52 94 36 95 359
2022/20231.916 188 124 37 324 236 306 0 230 328 19 81 43
2023/2024459 93 41 15 16 133 102 6 32 9 12 0 0
Totale 7.358